Human Formulations

Nebivolol 2.5mg + Cilnidipine 10mg Tablets (Film coated bilyered)

Nebivolol 2.5mg + Cilnidipine 10mg Tablets (Film coated bilyered) is a tablet formulated with Nebivolol 2.5mg + Cilnidipine 10mg ( bilyered). The listed active ingredient profile is Nebivolol; Cilnidipine, placing the product in the antihypertensive / car

Therapeutic RangesCardiac Range Single Ingredient Tablet
Sterile injectable formulation

Product information

Product Line
Human Formulations
Category
Therapeutic Ranges, Cardiac Range
Dosage Form
Tablet
Product Type
Single Ingredient

Available strengths

Nebivolol 2.5mg + Cilnidipine 10mg ( bilyered)Nebivolol 5mg + Cilnidipine 10mg ( bilyered)

Description

Nebivolol 2.5mg + Cilnidipine 10mg Tablets (Film coated bilyered) is a tablet formulated with Nebivolol 2.5mg + Cilnidipine 10mg ( bilyered). The listed active ingredient profile is Nebivolol; Cilnidipine, placing the product in the antihypertensive / cardiovascular category. The formulation contains one or more cardiovascular medicines used to lower blood pressure or manage related cardiovascular conditions. The source identifies the dosage form as tablet with film coated presentation. For website cataloguing, the composition, strength, dosage form and formulation characteristics should be displayed prominently and consistently. The product description should remain factual and should not include unapproved cure, superiority, guaranteed-result or broad therapeutic claims. Clinical selection should depend on diagnosis, patient-specific factors, contraindications, concomitant medicines and professional judgement. Prescription status, warnings, interactions, adverse effects and dosing or application instructions must be checked against the current approved product label. Manufacturer, licence, storage, shelf-life, reconstitution where applicable, and market-specific regulatory details should be added only from verified product documentation.
WHO-GMP Sourced
Sterile Supply
Regulatory Documentation
Quality Assured